Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1B | Q00975 | 1/20 | 0.47 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | CYP3A5 | P20815 | 2/20 | 0.44 |
| ▸ | CYP3A7 | P24462 | 2/20 | 0.44 |
| ▸ | CYP3A43 | Q9HB55 | 2/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | PSMB8 | P28062 | 3/20 | 0.43 |
| ▸ | ITGB1 | P05556 | 2/20 | 0.43 |
| ▸ | ITGA4 | P13612 | 2/20 | 0.43 |
| ▸ | ITGB7 | P26010 | 2/20 | 0.43 |
| ▸ | YAP1 | P46937 | 1/20 | 0.42 |
| ▸ | TMPRSS11D | O60235 | 1/20 | 0.42 |
| ▸ | CTRL | P40313 | 1/20 | 0.42 |
| ▸ | PSMB5 | P28074 | 7/20 | 0.41 |
| ▸ | PSMB9 | P28065 | 3/20 | 0.41 |
| ▸ | PSMB11 | A5LHX3 | 2/20 | 0.41 |
| ▸ | PSMA7 | O14818 | 2/20 | 0.41 |
| ▸ | PSMB1 | P20618 | 2/20 | 0.41 |
| ▸ | PSMA1 | P25786 | 2/20 | 0.41 |
| ▸ | PSMA2 | P25787 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8298346 | 0.94 | CACNA1B (0.46) | CACNA1BCYP3A4CYP3A5CYP3A7CYP3A43 | |
| SCHEMBL6474215 | 0.93 | ITGB1 (0.46) | CACNA1BPSMB8ITGB1ITGA4ITGB7 | |
| SCHEMBL6473763 | 0.91 | ITGB1 (0.44) | CACNA1BITGB1ITGA4ITGB7YAP1 | |
| SCHEMBL7478643 | 0.91 | ITGB1 (0.44) | CACNA1BITGB1ITGA4ITGB7YAP1 | |
| SCHEMBL6474049 | 0.90 | EPHX1 (0.46) | CACNA1BCYP3A4CYP3A5CYP3A7CYP3A43 | |
| SCHEMBL6474041 | 0.90 | CTSS (0.45) | CACNA1BCYP3A4CYP3A5CYP3A7CYP3A43 | |
| SCHEMBL6480951 | 0.89 | MAPK1 (0.47) | CACNA1BPSMB8ITGB1ITGA4ITGB7 | |
| SCHEMBL6474104 | 0.89 | KMT2A (0.45) | CACNA1BCYP3A4CYP3A5CYP3A7CYP3A43 | |
| SCHEMBL6480791 | 0.88 | YAP1 (0.46) | PSMB8ITGB1ITGA4ITGB7YAP1 | |
| SCHEMBL6480784 | 0.88 | CACNA1B (0.47) | CACNA1BCYP3A4CYP3A5CYP3A7CYP3A43 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6867192-B1 | Compounds useful in the treatment of inflammatory diseases | GLAXO GROUP LIMITED (GB) | 2005-03-15 | — | — | US | claimed |
| EP-1140837-B1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LTD (GB) | 2004-08-18 | — | — | EP | claimed |
| EP-1140837-A1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2001-10-10 | — | — | EP | claimed |
| WO-2000037444-A1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2000-06-29 | — | — | WO | claimed |
| US-6867192-B1 | Compounds useful in the treatment of inflammatory diseases | GLAXO GROUP LIMITED (GB) | 2005-03-15 | — | — | US | disclosed |
| EP-1140837-B1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LTD (GB) | 2004-08-18 | — | — | EP | disclosed |
| EP-1140837-A1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000037444-A1 | COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES | GLAXO GROUP LIMITED (GB) | 2000-06-29 | — | — | WO | disclosed |